Ramelteon Tablet
Product Images NDC 70710-1344

2 FDA label images from Zydus Pharmaceuticals Usa Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ramelteon (NDC 70710-1344). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (6bc89997 A72b 415e 93d9 442ce2579bca 01)

Image (6bc89997 A72b 415e 93d9 442ce2579bca 01)
Chemical structure of Ramelteon, showing its molecular framework including a fused bicyclic ring system and associated functional groups.*
FDA Label Image

8 mg (6bc89997 A72b 415e 93d9 442ce2579bca 02)

8 mg (6bc89997 A72b 415e 93d9 442ce2579bca 02)
Packaging label for Ramelteon Tablets 8 mg oral tablets by Zydus Pharmaceuticals USA Inc. The package contains 30 tablets with Rx only status. The label features dosing and storage instructions, child-resistant packaging indication, and contact information for medication guide access.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.